John R Moore insider trades: Edgewise Therapeutics (EWTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
30 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | EWTX | ↓ Sell | 5,016 | $43.82 | $220K | Direct | Aug 14, 2026 (2d) |
| Aug 12, 2025 | EWTX | ↓ Sell | 2,098 | $13.39 | $28K | Direct | Aug 14, 2025 (2d) |
| May 2, 2025 | EWTX | ↓ Sell | 1,930 | $16.45 | $32K | Direct | May 7, 2025 (5d) |
| Sep 23, 2024 | EWTX | ↓ Sell | 70,922 | $28.15 | $2.0M | Direct | Sep 24, 2024 (1d) |
| May 2, 2024 | EWTX | ↓ Sell | 1,956 | $18.91 | $37K | Direct | May 3, 2024 (1d) |
| Feb 9, 2024 | EWTX | ↓ Sell | 29,835 | $20.00 | $597K | Direct | Feb 9, 2024 (0d) |
| Dec 27, 2023 | EWTX | ↓ Sell | 8,497 | $10.50 | $89K | Direct | Dec 28, 2023 (1d) |
| May 2, 2023 | EWTX | ↓ Sell | 1,897 | $8.90 | $17K | Direct | May 3, 2023 (1d) |
| Oct 3, 2022 | EWTX | ↓ Sell | 4,730 | $9.76 | $46K | Direct | Oct 5, 2022 (2d) |
| Sep 6, 2022 | EWTX | ↓ Sell | 4,730 | $10.91 | $52K | Direct | Sep 8, 2022 (2d) |
| Aug 3, 2022 | EWTX | ↓ Sell | 9,232 | $9.31 | $86K | Direct | Aug 5, 2022 (2d) |
| Jul 6, 2022 | EWTX | ↓ Sell | 9,232 | $8.37 | $77K | Direct | Jul 7, 2022 (1d) |
| Jun 21, 2022 | EWTX | ↓ Sell | 67,927 | $6.83 | $464K | Direct | Jun 21, 2022 (0d) |
| Jun 15, 2022 | EWTX | ↓ Sell | 26,381 | $6.08 | $160K | Direct | Jun 15, 2022 (0d) |
| Jun 10, 2022 | EWTX | ↓ Sell | 27,306 | $6.44 | $176K | Direct | Jun 10, 2022 (0d) |
| Jun 7, 2022 | EWTX | ↓ Sell | 47,287 | $6.26 | $296K | Direct | Jun 7, 2022 (0d) |
| May 16, 2022 | EWTX | ↓ Sell | 10,800 | $7.42 | $80K | Direct | May 18, 2022 (2d) |
| Nov 29, 2013 | ARRY | ↓ Sell | 11,666 | $5.79 | $68K | Direct | Dec 3, 2013 (4d) |
| Nov 13, 2013 | ARRY | ↓ Sell | 200 | $5.79 | $1K | Direct | Nov 15, 2013 (2d) |
| Aug 2, 2013 | ARRY | ↓ Sell | 75,384 | $7.02 | $529K | Direct | Aug 2, 2013 (0d) |
| Jul 23, 2013 | ARRY | ↓ Sell | 5,000 | $6.50 | $33K | Direct | Jul 25, 2013 (2d) |
| Oct 8, 2012 | ARRY | ↓ Sell | 26,190 | $5.69 | $149K | Direct | Oct 9, 2012 (1d) |
| Oct 8, 2012 | ARRY | ↓ Sell | 2,357 | $5.69 | $13K | Held by spouse | Oct 9, 2012 (1d) |
| Apr 5, 2011 | ARRY | ↓ Sell | 356 | $3.30 | $1K | Held by spouse | Apr 5, 2011 (0d) |
| Jan 11, 2011 | ARRY | ↓ Sell | 2,959 | $3.30 | $10K | Held by spouse | Jan 12, 2011 (1d) |
| Jan 6, 2011 | ARRY | ↓ Sell | 24,039 | $3.25 | $78K | Direct | Jan 6, 2011 (0d) |
| Oct 5, 2010 | ARRY | ↓ Sell | 20,067 | $3.29 | $66K | Direct | Oct 6, 2010 (1d) |
| Aug 3, 2010 | ARRY | ↓ Sell | 6,319 | $3.25 | $21K | Direct | Aug 4, 2010 (1d) |
| Nov 20, 2006 | ARRY | ↓ Sell | 27,263 | $13.04 | $356K | Direct | Nov 20, 2006 (0d) |
| Feb 17, 2006 | ARRY | ↓ Sell | 4,456 | $9.38 | $42K | Direct | Feb 22, 2006 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EWTX insiders
Open-market trades in the last 12 months
About John R Moore's insider trades
John R Moore is General Counsel at Edgewise Therapeutics (EWTX). Since Feb 17, 2006, John has reported no open-market purchases and 30 sales worth $5.8M on SEC Form 4. In the last 12 months: 1 sale ($220K).
Their filings also include grants and awards (27 filings), option exercises (23 filings), shares withheld for taxes (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EWTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.